Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study
✍ Scribed by David Martinez-Gomez; Sonia Gomez-Martinez; M Angeles Puertollano; Esther Nova; Julia Wärnberg; Oscar L Veiga; Amelia Martí; Cristina Campoy; Jesus M Garagorri; Cristina Azcona; M Pilar Vaquero; Carlos Redondo-Figuero; Manuel Delgado; J Alfredo Martínez; Miguel Garcia-Fuentes; Luis A Moreno; Ascension Marcos; EVASYON Study Group
- Book ID
- 115016285
- Publisher
- BioMed Central
- Year
- 2009
- Tongue
- English
- Weight
- 475 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1471-2458
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Moxonidine is a centrally active imidazoline receptor agonist that effectively lowers blood pressure and has been shown to have beneficial effects on lipid and carbohydrate metabolism. We assessed the efficacy of moxonidine in a postmarketing surveillance study (CAMUS) conducted in 772 practices in